Name: 10th International Conference on Endocrinology, Diabetes & Metobolism
Start: 2026-09-17
End: 2026-09-19
Location: France

Conference Information

Welcome message

Step Into the Future of Endocrinology at Diabetics 2026.

Warm Greetings!

10th International Conference on Endocrinology, Diabetics & Metabolism

September 17-18, 2026|Paris, France

Be part of a premier international event dedicated to the advancement of diabetes, endocrinology, and metabolic science. Hosted in the cultural and scientific hub of Paris, the 10th International Conference on Endocrinology, Diabetes & Metabolism will provide a platform for experts worldwide to present pioneering research, discuss innovative therapies, and shape the future of metabolic healthcare through global collaboration.

Theme: “Uniting Global Experts to Transform Diabetes Care”.

The Unique Value of This Congress:

Advancing Global Diabetes Care: With diabetes and metabolic disorders increasing worldwide, improving prevention, early diagnosis, and treatment has become essential. The event brings together experts to discuss emerging research and practical strategies that support better global diabetes management.

Promoting Global Scientific Collaboration: This conference will unite endocrinologists, Diabetologists, researchers, and healthcare professionals worldwide to exchange knowledge and strengthen collaborations in diabetes research.

Connect with international experts at Diabetics 2026 to drive progress in diabetes and endocrine science.

About conference

Main Moto-Advancing Diabetes Research for a Healthier Future

Join us for the 10th International Conference on Endocrinology, Diabetes & Metabolism, taking place on September 17–18, 2026, in Paris, France. This conference will showcase innovative research, clinical insights, and technological advancements in diabetes and endocrine science. The event will provide an excellent opportunity for global experts to exchange ideas, explore new research directions, and build partnerships aimed at improving diabetes care worldwide.

Key Benefits of Participation

Certificate of Participation
Best Presentation Awards
Young Researcher Awards
Global Networking Opportunities
Presenter Recognition Certificates, And many more….

Target Audience/ Who Can Take Part

Endocrinologists and Diabetologists
Physicians and Medical Practitioners
Medical and Life Science Students
Healthcare Professionals and Nurses
Nutritionists and Dietitians
Public Health Specialists

Scientific Sessions

Session 1: Diabetes Research

This session on Diabetes research at Diabetics 2026 focuses on understanding the biological, genetic, and environmental factors that contribute to the development and progression of diabetes. Ongoing scientific studies aim to improve early diagnosis, discover new treatment approaches, and prevent diabetes-related complications. This session will highlight recent research findings, innovative therapeutic strategies, and emerging technologies that are advancing diabetes care and improving patient outcomes.

Sub-Tracks:

Basic Diabetes Research
Molecular Mechanisms of Diabetes
Genetics and Epigenetics in Diabetes
Pathophysiology of Diabetes
Novel Therapeutic Targets

2. Clinical Endocrinology

The Session on Clinical endocrinology at Diabetics 2026 focuses on the diagnosis, treatment, and management of disorders related to the endocrine system and hormone regulation. As endocrine diseases such as diabetes, thyroid disorders, and metabolic syndromes continue to rise globally, advances in clinical research and therapeutic strategies are essential for improving patient care. This session will explore current clinical practices, emerging treatments, and innovative approaches in the management of endocrine and metabolic disorders.

Sub-Tracks:

Clinical Endocrine Disorders
Hormonal Regulation and Imbalances
Thyroid Disorders and Management
Adrenal and Pituitary Disorders
Endocrine Complications in Diabetes

3. Diabetes & Metabolic Disorders

This session on Diabetes and metabolic disorders at Diabetics 2026 will highlight current research, clinical advances, and preventive strategies aimed at improving the diagnosis, treatment, and management of diabetes and related metabolic conditions. The Diabetes and metabolic disorders are major global health concerns affecting millions of people worldwide. These conditions involve complex interactions between genetics, lifestyle, and metabolic processes that influence glucose regulation, energy balance, and overall health.

Sub-Tracks:

Metabolic Pathways
Insulin Resistance
Metabolic Syndrome
Lipid Metabolism
Hormonal Regulation
Metabolic Complications

4. Obesity & Cardio metabolic Risk

The Obesity & Cardio metabolic risk session at Diabetics 2026 will highlight emerging research, clinical approaches, and preventive measures that address cardio metabolic complications linked to excess body weight. Obesity is widely recognized as a significant contributor to conditions such as type 2 diabetes, cardiovascular disease, and metabolic disorders. Understanding the complex relationship between excess body weight, metabolic imbalance, and heart health is essential for effective prevention and treatment.

Sub-Tracks:

Obesity Epidemiology
Metabolic Syndrome
Insulin Resistance
Cardiovascular Risk
Lipid Disorder

5.Endocrine Genomics

This Session on Endocrine genomics at Diabetics 2026 explores how genetic variations influence endocrine functions and the development of hormone-related disorders. Advances in genomic technologies are improving the understanding of disease mechanisms, enabling early diagnosis, and supporting personalized treatment strategies. This session will highlight recent discoveries and innovative approaches in genomic research related to endocrine and metabolic health.

Sub-Tracks:

Genomic Technologies
Gene Expression
Genetic Variations
Epigenetic Regulation
Hormone Genetics

6.Gestational Diabetes

The Gestational diabetes Session at Diabetics 2026 highlights recent clinical insights, screening approaches, and care strategies aimed at improving outcomes for mothers and infants .Gestational diabetics is a metabolic condition that occurs during pregnancy and can influence both maternal health and fetal development. Timely identification and appropriate management are important to reduce complications during pregnancy and delivery.

Sub-Tracks:

Pregnancy Metabolism
Risk Factors
Screening Methods
Maternal Outcomes
Fetal Health

7. Nutrition and diet

This Session on Nutrition and diet at Diabetics 2026 play a significant role in maintaining metabolic health and managing diabetes .Balanced nutrition can support glucose control, reduce complications, and improve overall well-being. This session presents current insights on dietary patterns, nutritional therapies, and evidence-based diet strategies that contribute to better diabetes management and prevention.

Sub-Tracks:

Medical Nutrition Therapy
Diabetic Diet Plans
Functional Foods
Glycemic Index
Preventive Nutrition

8. Gut Micro biome & Metabolism

The gut micro biome & Metabolism Session at Diabetics 2026 considers recent scientific findings on how the gut micro biome influences metabolic health and highlights emerging therapeutic strategies targeting micro biota to improve metabolic outcomes Alterations in gut microbial communities are increasingly linked with metabolic disorders such as diabetes and obesity .The gut micro biome has an important role in metabolic regulation, energy balance, and immune function.

Sub-Tracks:

Gut Micro biota
Microbial Diversity
Host–Microbe Interactions
Metabolic Pathways
Micro biome Dysbiosis

9.Stem Cell Therapy

This Session on Stem cell therapy at Diabetics 2026 offers promising opportunities for repairing damaged tissues and restoring pancreatic function in diabetes. Advances in regenerative medicine and cell-based treatments are opening new possibilities for improving long-term disease management. This session presents current progress in stem cell research, clinical applications, and innovative strategies aimed at developing effective therapies for diabetes and related metabolic disorders.

Sub-Tracks:

Stem Cell Biology
Beta Cell Regeneration
Cell-Based Therapy
Pancreatic Regeneration
Tissue Engineering

10.Immunotherapy for Type 1 Diabetes

The Immunotherapy for Type 1 diabetes session at Diabetics 2026 emphasizes recent developments in immune-based treatments and research efforts aimed at improving long-term outcomes for individuals with type 1 diabetes. Type 1 diabetes results from an autoimmune response that damages insulin-producing beta cells in the pancreas. Immunotherapy offers promising possibilities to modify immune activity, preserve remaining beta cells, and delay disease progression.

Sub-Tracks:

Autoimmune Mechanisms
Immune Modulation
T-Cell Responses
Beta Cell Protection
Antigen-Specific Therapy

11. Nanotechnology

This Session on Nanotechnology at Diabetics 2026 deals with recent progress in nanotechnology applications that contribute to better detection, management, and treatment of diabetes. Nanotechnology is opening new possibilities in diabetes research and treatment through advanced drug delivery systems, improved diagnostics, and targeted therapies. Nanoscale materials and devices enable precise monitoring and controlled release of therapeutic agents, enhancing treatment efficiency.

Sub-Tracks:

Nanomedicine
Nano Drug Delivery
Nano Diagnostics
Nano materials Research
Targeted Therapy

12.Diabetes Biomarkers & Metabolomics

The Diabetics Biomarkers and metabolomics Session at Diabetics 2026 Covers recent findings in biomarker discovery and metabolomics analysis that contribute to earlier detection and improved management of diabetes.The Biomarkers and metabolomic profiling are advancing the understanding of diabetes development and progression. These approaches help identify molecular indicators associated with disease risk, diagnosis, and treatment response.

Sub-Tracks:

Biomarker Discovery
Metabolomic Profiling
Molecular Signatures
Diagnostic Biomarkers
Predictive Markers

13.Lifestyle & Diabetes Prevention

The Lifestyle & Diabetes prevention Session at Diabetics 2026 examines evidence-based lifestyle approaches and community strategies that contribute to effective diabetes prevention and health promotion The Life style choices play an essential role in reducing the risk of diabetes and supporting long-term metabolic health. Healthy habits such as balanced nutrition, regular physical activity, and weight management can significantly lower the chances of developing type 2 diabetes.

Sub-Tracks:

Healthy Lifestyle
Physical Activity
Dietary Habits
Weight Management
Preventive Health

14. Global Diabetes Epidemiology

The Global diabetes epidemiology Session at Diabetics 2026 examines the distribution, determinants, and trends of diabetes across different populations and regions. Understanding these patterns supports better public health planning, early intervention, and effective prevention strategies. This session provides an overview of population-based studies, global data trends, and research insights that contribute to improving diabetes control worldwide.

Sub-Tracks:

Global Prevalence
Disease Burden
Population Studies
Risk Factors
Regional Trends

15.Telemedicine in Diabetes Care

This Session on Telemedicine in Diabetics care at Diabetics 2026 Outlines recent developments in telehealth technologies and digital tools that enhance diabetes care and patient engagement is transforming diabetes management by enabling remote monitoring, digital consultations, and improved access to healthcare services. Virtual care platforms support continuous glucose monitoring, patient education, and timely clinical guidance.

Sub-Tracks:

Telehealth Platforms
Remote Monitoring
Digital Health Tools
Virtual Consultations
Mobile Health Apps

16.Insulin Therapy

This Session on Insulin therapy at Diabetics 2026 remains a cornerstone in the management of diabetes, particularly for individuals with type 1 diabetes and advanced type 2 diabetes. Continuous improvements in insulin formulations and delivery methods are enhancing glycemic control and patient convenience. This session shares recent clinical developments, treatment approaches, and technological advancements that support effective insulin use in diabetes care.

Sub-Tracks:

Insulin Analogues
Basal Insulin
Bolus Insulin
Insulin Delivery
Insulin Pumps

17. Artificial Pancreas Technology

The Artificial pancreas technology Session at Diabetics 2026 represents a major advancement in diabetes management by integrating continuous glucose monitoring with automated insulin delivery systems. These technologies aim to maintain stable glucose levels and reduce the burden of daily diabetes care. This session addresses recent developments in closed-loop systems, device innovation, and clinical applications that support improved glycemic control for people living with diabetes.

Sub-Tracks:

Closed-Loop Systems
Glucose Sensors
Automated Insulin Delivery
Smart Insulin Pumps
Continuous Monitoring

18.Diabetes & Aging

The Diabetes & Aging Session at Diabetics 2026 discusses clinical perspectives, research findings, and care strategies aimed at improving metabolic health and quality of life among the elderly population with diabetes. The growing aging population has led to an increasing number of older adults living with diabetes. Age-related physiological changes, multiple health conditions, and medication considerations create unique challenges in diabetes management.

Sub-Tracks:

Aging and Metabolism
Geriatric Diabetes
Age-Related Complications
Comorbidity Management
Cognitive Health

19. Neuroendocrinology

This Session on Neuroendocrinology at Diabetics 2026 studies the interactions between the nervous system and the endocrine system in regulating hormones, metabolism, and physiological balance. These interactions influence many metabolic processes, including glucose regulation and energy homeostasis. This session explores current research and clinical insights into neuroendocrine pathways and their relevance to metabolic and endocrine disorders.

Sub-Tracks:

Neuroendocrine Signalling
Brain–Hormone Interactions
Hypothalamic Regulation
Neuroendocrine Pathways
Hormonal Control

20.Artificial Intelligence in Diabetes Care

This Session on AI in Diabetes Care at Diabetics 2026 showcases a recent developments in intelligent technologies that enhance diagnosis, treatment planning, and patient-centered diabetes care. The artificial Intelligence increasingly contributing to improved diabetes management through advanced data analysis, predictive modeling, and personalized treatment strategies.AI-driven tools can assist in glucose monitoring, risk assessment, and clinical decision support.

Sub-Tracks:

AI Algorithms
Predictive Analytics
Glucose Prediction

Smart Monitoring
AI Diagnostics

21. Advances in Diabetic Foot Care

The Advances in Diabetic foot Care Session at Diabetics 2026 highlights recent developments in prevention, clinical care, and innovative therapies for diabetic foot management. The Diabetic foot complications remain a significant concern for individuals living with diabetes, often leading to infections, ulcers, and mobility challenges. Progress in wound management, early diagnosis, and multidisciplinary treatment approaches is improving patient outcomes and reducing the risk of severe complications.

Sub-Tracks:

Diabetic Foot Ulcers
Wound Management
Infection Control
Limb Preservation
Vascular Assessment

22. Case Report and Case Studies

The Case reports and case studies Session at Diabetics 2026 contribute valuable clinical insights by presenting unique patient experiences, rare conditions, and unexpected treatment outcomes. These observations support medical learning, highlight diagnostic challenges, and encourage discussion on effective clinical decision-making. This session provides a platform for sharing noteworthy cases that enhance understanding and practice in diabetes and endocrine care.

Sub-Tracks:

Rare Diabetes Cases
Clinical Case Reports
Diagnostic Challenges
Treatment Outcomes
Complex Cases

Market Analysis

Market Analysis:

Global Diabetes Burden

In 2024, nearly 589 million adults across the world were affected by diabetes.
Projections indicate that this figure may surpass 850 million by 2050.
The steady rise in cases highlights the increasing demand for stronger research initiatives, prevention programs, and improved therapeutic solutions.

CAGR Value (2026–2030)

The global anti diabetic drug market is forecasted to expand at an estimated CAGR of about 10.7% between 2024 and 2030.
The Type 2 diabetes treatment market is predicted to grow at a CAGR of approximately 6–7% by 2030.
The digital diabetes management sector, including telehealth and remote monitoring technologies, is expected to grow at a CAGR of around 12–15% by 2030.
Key factors supporting this growth include continuous glucose monitoring systems, AI-enabled healthcare solutions, and digital therapeutic innovations.

Here’s the assumed CAGR graph for diabetes market from 2026-2030

Importance of Diabetes Conferences

Encourage international exchange of knowledge in endocrinology and metabolic science.
Provide opportunities for researchers to share clinical findings and emerging healthcare technologies.
Strengthen partnerships among academic researchers, clinicians, and industry professionals.
Promote professional networking and inspire innovation in diabetes prevention and management.

Future Opportunities

Expansion of precision medicine and individualized diabetes treatment strategies.
Advancement of artificial pancreas technologies and automated insulin delivery systems.
Wider adoption of digital health tools and telemedicine for diabetes monitoring and care.
Continued progress in regenerative medicine and stem cell–based therapeutic approaches.

10th International Conference on
Endocrinology, Diabetes & Metobolism

Quick Links

Theme: Uniting Global Experts to Transform Diabetes Care

Conference Information

Welcome message

About conference

Scientific Sessions

Market Analysis